Enbrel Myclic Pen Inj acquires commercialization approval
Pfizer Pharmaceuticals Korea(CEO/President Dong-Wook Oh) acquired commercialization approval for a pen-type administration of Enbrel(generic name: etanercept), a rheumatoid arthritis therapy, ‘Enbrel Myclic Pen Inj 50mg.’ Enbrel Myclic Pen allows patients to easily take injections with the auto-i...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
